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Summary.-The results of treatment of female breast cancer in the Cambridge area
during the period 1960-71 are presented and compared with an earlier series treated
in the period 1947-50. It is estimated that about29°, ofthe patients treated in the later
period are cured, in the sense that they have a life expectancy similar to that of the
normal population, compared with just under 20% in the earlier period, but this
improvement is mainly due to an increased proportion of Stage I cases in the later
period. The percentage cured is discussed in relation to the ratio of deaths to registra-
tions in the East Anglian Region and it is suggested that under-registration of
deaths from cancer of the breast may occur.
AT THE END of the 1950s Dr Diana
Brinkley and I carried out a study on the
results of treatment of 704 patients with
female breast cancer seen in the Cam-
bridgeshire Area from 1947 to 1950
(Brinkley & Haybittle, 1959). The long-
term follow-up of this series (Brinkley &
1-laybittle, 1975) suggested that just under
20% ofall patients were cured in the sense
that they had a life expectancy similar to
that of the normal population. Neverthe-
less, although the death rate in the series
between 20 and 25 years was almost the
same as that of a normal population, 8/23
deaths after 20 years were from cancer of
the breast, which is about 16 x the number
that would be expected from canicer ofthe
breast in the normal population. No cancer
registry was operating in the Cambridge
area at the time when the patients were
treated and, although we endeavoured to
collect as representative a group as
possible of breast-cancer patients, we were
aware that the series was probably
deficient in operable cases treated by
surgery only, and also perhaps in late
Stage IV cases who were never referred
anywhere for treatment.
If one looks at the natioinal figures for
deaths and registrations of female cancer
of the breast, the former are about 60%
of the latter, which seems surprising if
only 200o or less of breast cancer patients
are cured. About one-tenth of the uncured
patients might still be expected to die of
some other disease before recurrence
manifested itself but this would still lead,
in a steady state situation, to deaths from
cancer of the breast being about 72% of
registrations. Also, the fact that many
patients cured in terms of life expectancy
still die of cancer of the breast would tend
to increase this figure.
Since 1960 a Cancer Registry Bureau
has been operating in the East Anglian
Region, and it has also been possible to
obtain from the G.R.O. the number of
deaths from cancer of the breast in East
Anglia. Fig. I shows how these have
varied from 1960 to 1976. First of all, in
any one year the ratio of deaths to regis-
trations is about 550. Secondly, through-
out the period there has been a steady
increase in both deaths and registrations.
Although part of the increase in registra-
tions can be due to an increased popula-BREAST-CANCER TREATMENT RESULTS 1960-71
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tion in this area, the dotted line in Fig. I
shows there has also been a real increase
in incidence per 100,000 females.
Obviously the registrations in any one
year give rise to deaths in later years, so
that to get an idea ofthe success rate from
these figures, it is more sensible to com-
pare the deaths with the registrations at
an earlier period. This is done in Table I
TABLE I.-Deaths and registrations of
cancer of the female breast in the East
Anglian Region
Per-io(d
1970-74
1965-69
1960-64
Deaths
1,975
1,720
RegistrIa-
tions
3,648
3,214
2,844
Deaths/
Registrations
5 years 10 year-s
prior prior
0 614 0-694
0-605
where it can be seen that when deaths are
compared with registrations 5 years
earlier the ratio is about 60%,, and if
compared with registrations 10 years
earlier about 70%1. But the median sur-
vival of the "uncured" patients is only
about 3 years, so that deaths in any one
year must be occurring in patients regis-
tered on average much less than 10 years
earlier, and the 5-year ratio is probably
the most appropriate. Thus, we still have
for East Anglia at least a 1000 discrepancy
in deaths/registrations if our "cured"
group is only 200/. To investigate this
discrepancy, a study has been made of
results of treatment of all female breast-
cancer patients registered in the Cam-
bridge Cancer Registry Bureau from 1960
to 1971 inclusive.
Patients treated in 1960-71
The first part of the investigation was
to see whether there had been any marked
changes either in clinical material or re-
sults over this 12-year period, and for this
purpose the period was divided into 3
4-vear intervals. Table II shows the total
number of patients and their mean age in
each interval. The numbers reflect the
increasing incidence already mentioned,
and there was no obvious trend or signifi-
cant change in the age of the patients
during the period. Fig. 2 shows the num-
bers ofpatients in different clinical stages.
The staging procedure used was uniform
throughout the period and based on the
TNM classification (IUCC, 1968). It can be
seen that the numbers of patients in
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On thie basis of this analysis of trhe indi-
vidual 4-year periods, it seems reasonable
to treat the whole group of patients fron
1-960 to 1971 as a single group for com-
parison with the 1947-50 series, and the
survival cuLrves for the 2 periods are
shown in Fig. 6. It is evi(lent that the
more recently treated patients aire doing
better, and the lifference between the 2
cuirves is highly significa,nt (x2 12 742;
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FIG. 7. Comparison of survival curs
1947-50 and 1960-71 patients
separated by stage.
are compared broken down I
(Fig. 7) the main improvement al
the Stage II cases, the only si
difference (X2 6-835; 0X01>I
being between the Stage II curve
The main change in treatmer
that occurred between the 2 per
an increased use of simple rat]
radical mastectomy as the prima
ment for operable cases. It could
seen in Stage II cases, but the results of a
clinical trial started in 1958 (Brinkley &
Haybittle, 1971) would not support this
view. It seems more likely that the
apparently improved result in the Stage II
cases is an artefact caused by the differ-
ence in the staging procedures used. In the
1947-50 series Stage II was defined as a
tumour confined to the breast without
involvement of skin or pectoral muscle,
but with palpable mobile nodes in the
(704) axilla ofthe same size. No notice was taken
ofthe tumour size. The TNM staging used
for the 1960-71 series places breast
tumours with diameters greater than 5 cm
For 1947-50 automatically in Stage III. This would
tend to improve the results in Stage II and
also in Sta'e III, a trend which is annarent
in Fig. 7.
Another change in the staging between
the 2 series is in the effect of supra-
clavicular nodes. In the older series their
presence placed a patient in Stage IV,
whilst in the 1960-71 series a supra-
clavicular node placed a patient in Stage
III. This would tend to improve results in
Stage IV in the earlier series and this also
is apparent in Fig. 7.
The cured group of 1960-71 patients
A comparison of the stage distribution
in the 2 series is shown in Fig. 8, where the
most apparent difference is the higher
number of unstaged cases in the earlier
series. The majority ofthese were operated
on, but the clinical findings before mast-
res for ectomy were inadequately recorded for
when staging purposes. Their survival rates
were very similar to those of the Stage II
cases in the same series (Brinkley &
by stage Haybittle, 1959).
ppears in If we make the comparison with the un-
ignificant staged cases excluded (Fig. 9) we can see
'>0 005) that the later series has a higher propor-
3s. tion of Stage I cases and a lower propor-
at policy tion of Stages II and IV. The differences
riods was in II's and IV's must to sonme extent be
her than accounted for by the changes in staging
ry treat- already mentioned, but the differences in
be postu- I's is probably a genuine effect due to the
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1947 - 50 1960 - 71
Fi(n. 9. Comparison of stage distributions in 1947-50 an(d 1960-71 patients when unstaged patients are
exclude(d.
known lack of comprehensive collection of
early operable cases for the 1947-50
series, and also perhaps a real trend to-
wards earlier referral. One must conclude
that the overall improvement in survival
results shown in Fig. 6 is probably a
reflection of the different clinical com-
position of the 2 groups rather than of
improved methods of treatment.
Fig. 10 shows the survival curve for the
1960-71 series in relation to the expected
survival of the normal population of the
same age distribution. The follow-up has
been too short to reach the situation where
the two curves might be running parallel,
although one can begin to see a suggestion
of this. An estimate of the cured group by
a mathematical model (Haybittle, 1965)
gives a value of29o%, and it does not seem
unreasonable to suppose that the survival
curve in Fig. 8 might approach and run
along the dotted curve drawn from 29%
at zero time. It is perhaps worth noting
that the use of the same mathematical
model on the data from the 1947-50 series
at a similar period of follow-up (19 years
after the first patient was treated) gave an
estimate of 20% for the cured group in
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Fic-. 10-.Estimate of cured group in 1960-71
patients. The dotted curve is clrawn parallel
to that of the expected survival of the
normal population, but starting from 29%
at zero time i.e. it represents the expectedl
survival of a cured grouip of 29%*
that series (Brinkley & Haybittle, 1968)
compared with the 18°/ figure estimated
by the model after a much longer follow-up
(Brinkley & Haybittle, 1975).
T)ISCUSSION
The estimate of 29% cured in the 1960-
71 series goes a long way towards explain-
ing the anomaly ofthe deaths/registrations
ratio mentioned at the beginning of this
paper. If one-tenth of the uncured group
die from other causes this would leave at
least 63°/ of the total group dying from
cancer of the breast, although this figure
would be increased by any excess deaths
from cancer of the breast in the "cured"
group. The ratio of deaths to registrations
5 years previously was about 61% (Table
I) which is still lower than the percentage
predicted from the cured group analysis,
but perhaps not unreasonable in view of
the inaccuracies of death certification. It
does, however, require that such in-
accuracies, if they exist, should lead to
under-registration of deaths from cancer
of the breast, rather than to over-regis-
tration.
I am very much indebted to Dr E. AM. Kingsley-
Pillers, Director of the Cambridge Cancer Registra-
tion Bureau, for allowing me access to the data for
the 1960-71 period, and to Dr Diana Brinkley for
first drawing my attention to the ratio of (leaths to
registrations in the national figures.
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